| Basics |
Orthofix Medical Inc.
Orthofix International NV is a medical device company. It focuses on providing reconstructive and regenerative orthopedic and spine solutions to physicians.
|
| IPO Date: |
April 24, 1992 |
| Sector: |
Healthcare |
| Industry: |
Health Care Equipment and Supplies |
| Market Cap: |
$629.63M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.48 | 1.46%
|
| Avg Daily Range (30 D): |
$0.29 | 1.87%
|
| Avg Daily Range (90 D): |
$0.24 | 1.66%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.13M |
| Avg Daily Volume (30 D): |
.19M |
| Avg Daily Volume (90 D): |
.25M |
| Trade Size |
| Avg Trade Size (Sh.): |
86 |
| Avg Trade Size (Sh.) (30 D): |
47 |
| Avg Trade Size (Sh.) (90 D): |
50 |
| Institutional Trades |
| Total Inst.Trades: |
2,620 |
| Avg Inst. Trade: |
$1.34M |
| Avg Inst. Trade (30 D): |
$.64M |
| Avg Inst. Trade (90 D): |
$.84M |
| Avg Inst. Trade Volume: |
.05M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.21M |
| Avg Closing Trade (30 D): |
$.64M |
| Avg Closing Trade (90 D): |
$.84M |
| Avg Closing Volume: |
48.23K |
|
|
| News |
Aug 6, 2025 @ 2:16 AM
Orthofix (OFIX) Q2 Revenue Rises 2%
Source: Jesterai
|
Apr 10, 2025 @ 5:30 AM
Intramedullary Nail Market size to worth USD 1,537...
Source: Coherent Market Insights
|
Feb 28, 2025 @ 3:56 PM
Prosthetic Disc Nucleus Market Outlook to Exceed U...
Source: Transparency Market Research Inc.
|
Nov 8, 2024 @ 9:00 PM
OFIX INVESTOR ALERT: Bronstein, Gewirtz & Grossman...
Source: Bronstein, Gewirtz & Grossman, Llc
|
Oct 30, 2024 @ 1:00 AM
ORTHOFIX ALERT: Bragar Eagel & Squire, P.C. is Inv...
Source: N/A
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$-3.03
|
$-.57
|
$-.36
|
|
Diluted EPS
|
$-3.03
|
$-.57
|
$-.36
|
|
Revenue
|
$ 818.06M
|
$ 205.63M
|
$ 203.12M
|
|
Gross Profit
|
$ 558.52M
|
$ 148.52M
|
$ 139.53M
|
|
Net Income / Loss
|
$ -119.12M
|
$ -22.8M
|
$ -14.08M
|
|
Operating Income / Loss
|
$ -93.4M
|
$ -17.05M
|
$ -16M
|
|
Cost of Revenue
|
$ 259.54M
|
$ 57.11M
|
$ 63.59M
|
|
Net Cash Flow
|
$ 32.84M
|
$ -2.64M
|
$ 7.18M
|
|
PE Ratio
|
|
|
|
|
|
|